Market Indices
Sector Heatmap
FDMT — 4D Molecular Therapeutics, Inc. Common Stock
Nasdaq4D Molecular Therapeutics, Inc. Common Stock
- O
- 14.12
- H
- 14.14
- L
- 13.60
- V
- 980.51K
FDMT — Latest News & Headlines
10 Stories4D Molecular Therapeutics (Nasdaq:FDMT) - Stock Analysis - Simply Wall Street
4D Molecular Therapeutics (Nasdaq:FDMT) - Stock Analysis Simply Wall Street
OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why - Stocktwits
OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why Stocktwits
A 9-person study reported 61% lower injection burden with 4D-150 versus a 13-shot projection. - Stock Titan
A 9-person study reported 61% lower injection burden with 4D-150 versus a 13-shot projection. Stock Titan
This is the top biotech stock pick from B Riley Securities - Yahoo Finance
This is the top biotech stock pick from B Riley Securities Yahoo Finance
Insiders At 4D Molecular Therapeutics Sold US$757k In Stock, Alluding To Potential Weakness - Moomoo
Insiders At 4D Molecular Therapeutics Sold US$757k In Stock, Alluding To Potential Weakness Moomoo
4D Molecular (FDMT) legal chief exercises options, then sells 1,635 shares - Stock Titan
4D Molecular (FDMT) legal chief exercises options, then sells 1,635 shares Stock Titan
OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD - TradingView
OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD TradingView
OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs - Stocktwits
OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs Stocktwits
4D Molecular Therapeutics Insiders Sold US$757k Of Shares Suggesting Hesitancy - Simply Wall Street
4D Molecular Therapeutics Insiders Sold US$757k Of Shares Suggesting Hesitancy Simply Wall Street
Scott Bizily sells $22,317 of 4D Molecular Therapeutics stock By Investing.com - Investing.com UK
Scott Bizily sells $22,317 of 4D Molecular Therapeutics stock By Investing.com Investing.com UK